CO5750041A1 - Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes - Google Patents

Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes

Info

Publication number
CO5750041A1
CO5750041A1 CO05094613A CO05094613A CO5750041A1 CO 5750041 A1 CO5750041 A1 CO 5750041A1 CO 05094613 A CO05094613 A CO 05094613A CO 05094613 A CO05094613 A CO 05094613A CO 5750041 A1 CO5750041 A1 CO 5750041A1
Authority
CO
Colombia
Prior art keywords
prevention
infants
manufacture
mixture
fatty acids
Prior art date
Application number
CO05094613A
Other languages
English (en)
Inventor
Carlos H Lifschitz
Nitida Pastor
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CO5750041A1 publication Critical patent/CO5750041A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

? Un método para la fabricación de un medicamento para la prevención de infecciones respiratorias en infantes caracterizado porque comprende mezclar una cantidad terapéuticamente efectiva de DHA y ARA. El método de acuerdo con la reivindicación 1, caracterizado porque la infección respiratoria se selecciona del grupo que consiste de infección respiratoria superior, influenza, crup, virus sincitial respiratorio, bronquitis, bronquiolitis y neumonía. El método de acuerdo con la reivindicación 1, caracterizado porque una cantidad terapéuticamente efectiva de DHA es entre 3 mg por kg de peso corporal por día y 150 mg por kg de peso corporal por día. El método de acuerdo con la reivindicación 1, caracterizado porque una cantidad terapéuticamente efectiva de ARA es entre 5 mg por kg de peso corporal por día y 150 mg por kg de peso corporal por día.
CO05094613A 2005-04-07 2005-09-19 Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes CO5750041A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66911105P 2005-04-07 2005-04-07
US11/114,892 US20060229366A1 (en) 2005-04-07 2005-04-26 Method for preventing or treating respiratory infections in infants

Publications (1)

Publication Number Publication Date
CO5750041A1 true CO5750041A1 (es) 2007-04-30

Family

ID=35432875

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05094613A CO5750041A1 (es) 2005-04-07 2005-09-19 Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes

Country Status (14)

Country Link
US (1) US20060229366A1 (es)
EP (1) EP1709961A1 (es)
KR (1) KR20060106583A (es)
AR (1) AR052641A1 (es)
BR (1) BRPI0503827A (es)
CA (1) CA2516873A1 (es)
CO (1) CO5750041A1 (es)
IN (1) IN2006CH00621A (es)
MX (1) MXPA05009927A (es)
NO (1) NO20055079L (es)
PA (1) PA8649001A1 (es)
RU (1) RU2005130292A (es)
SG (1) SG126810A1 (es)
TW (1) TW200635574A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
KR101597372B1 (ko) 2007-11-01 2016-02-24 엔지모테크 리미티드 유아 영양을 위한 지질 혼합물
WO2012012498A2 (en) * 2010-07-20 2012-01-26 Pulmatrix, Inc. Use of trp channel agonists to treat infections
CN103228273B (zh) 2010-09-29 2017-04-05 普马特里克斯营业公司 吸入用单价金属阳离子干粉剂
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
WO2022226311A1 (en) * 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
CN1660065A (zh) * 1997-03-27 2005-08-31 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
US6180671B1 (en) * 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US20040143013A1 (en) * 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält

Also Published As

Publication number Publication date
NO20055079L (no) 2006-10-09
IN2006CH00621A (es) 2007-06-15
PA8649001A1 (es) 2006-10-13
SG126810A1 (en) 2006-11-29
EP1709961A1 (en) 2006-10-11
RU2005130292A (ru) 2007-04-10
KR20060106583A (ko) 2006-10-12
AR052641A1 (es) 2007-03-28
TW200635574A (en) 2006-10-16
NO20055079D0 (no) 2005-10-31
BRPI0503827A (pt) 2006-12-19
CA2516873A1 (en) 2006-10-07
US20060229366A1 (en) 2006-10-12
MXPA05009927A (es) 2006-10-01

Similar Documents

Publication Publication Date Title
CY1124720T1 (el) Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων
HRP20160605T1 (hr) Tetraciklički spoj
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
BR112013022044A2 (pt) veículo mastigável para absorção na boca
MX2010001839A (es) Metodo y aparato para comunicacion y metodo y aparato para controlar comunicacion.
CO5750041A1 (es) Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes
GT200500384A (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
ECSP066715A (es)
HN2001000037A (es) Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
ES2916604T1 (es) Ensayos de detección de nrf2 y métodos y composiciones relacionados
WO2006029081A3 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
UY29377A1 (es) Nuevas formilaciones líquidas de rotavirus, su preparación y sus usos.
BR0210261A (pt) Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes
AR082579A2 (es) Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
PE20061314A1 (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
MX354423B (es) Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
CO6640318A2 (es) Formas de dosificación oral de bendamustina
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
BRPI0410044A (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
GT200800235A (es) Formulacion de medicamento liquida
JP2015522040A5 (es)
BRPI0508767A (pt) composição que apresenta palatabilidade aprimorada, partìculas secas por congelamento peneiradas, partìculas secas por congelamento semelhantes a pó comprimìvel e de livre fluxo, processo para fabricar as mesmas, composições farmacêuticas com palatabilidade aprimorada, método para fabricar as mesmas e método para fabricar comprimidos

Legal Events

Date Code Title Description
FA Application withdrawn